StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$13.88−1.18 (-7.81%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

SkinHealth Systems gross margin

Gross margin is gross profit as a percentage of revenue.

SkinHealth Systems's gross margin for the twelve months ending Jun 30, 2026 was 66.4%. For fiscal 2025 it was 65.3%, against 54.5% the year before. The highest annual figure on record is 68.6% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202565.3%+10.8
FY2024Dec 31, 202454.5%+15.6
FY2023Dec 31, 202339.0%−29.0
FY2022Dec 31, 202268.0%−0.7
FY2021Dec 31, 202168.6%+12.2
FY2020Dec 31, 202056.4%−7.5
FY2019Dec 31, 201963.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202668.4%+5.6
Q1 FY2026Mar 31, 202668.5%−1.4
Q4 FY2025Dec 31, 202564.4%+1.7
Q3 FY2025Sep 30, 202564.6%+13.0
Q2 FY2025Jun 30, 202562.8%+17.6
Q1 FY2025Mar 31, 202569.8%+10.4
Q4 FY2024Dec 31, 202462.7%+15.5
Q3 FY2024Sep 30, 202451.6%+64.5
Q2 FY2024Jun 30, 202445.2%−12.6
Q1 FY2024Mar 31, 202459.4%−3.3
Q4 FY2023Dec 31, 202347.2%−20.6
Q3 FY2023Sep 30, 2023-12.9%−82.0
Q2 FY2023Jun 30, 202357.8%−9.9
Q1 FY2023Mar 31, 202362.7%−4.8
Q4 FY2022Dec 31, 202267.8%−0.9
Q3 FY2022Sep 30, 202269.1%+1.5
Q2 FY2022Jun 30, 202267.6%−3.4
Q1 FY2022Mar 31, 202267.5%+0.7
Q4 FY2021Dec 31, 202168.7%+7.8
Q3 FY2021Sep 30, 202167.6%+7.0
Q2 FY2021Jun 30, 202171.0%+40.8
Q1 FY2021Mar 31, 202166.8%–
Q4 FY2020Dec 31, 202060.8%–
Q3 FY2020Sep 30, 202060.6%–
Q2 FY2020Jun 30, 202030.3%–

More SkinHealth Systems figures

See a number that looks wrong?